Beautiful Virgin Islands

Monday, Oct 06, 2025

Why America Is Beating Europe on Vaccination

Why America Is Beating Europe on Vaccination

Last summer, France’s pandemic response seemed far more competent than America’s. In the vaccine stage, everything looks different.
Up until a few months ago, I’d felt sorry for my American friends and family, stuck in a Trumpian nightmare of science denial and a warped fealty to personal liberty so extreme that, even as pandemic casualties soared, some people took to screaming, even spitting, at anyone who told them to put on a face mask. The situation in France, where I live, was more under control. Today, however, as the greater Paris region suffers through a third lockdown in response to the new viral wave sweeping the country, the tables have turned. Pandemic competence now is all about access to vaccines in a global race to beat a fast-mutating virus with mass inoculations—and the U.S. is clearly leading Europe.

My parents and three siblings in the United States are now vaccinated. Even my 30-something French stepdaughter and her husband, expats in Texas, have had their first shots. Me? As a healthy 63-year-old, I will not be eligible to get vaccinated in France, according to the official government calendar, until mid-May, because as the doses trickle in, people who are more frail, older, and more essential workers than I am have priority. That’s nearly another two months to wait. And when I can finally get my first jab, I will likely not have a choice of vaccines and may well be offered AstraZeneca, which, safety and drug-trial concerns aside, means a 12-week wait for the second dose. Assuming I can get an appointment on day one of my eligibility—which I probably can’t—I won’t be fully vaccinated until mid-August. So much for the summer of 2021.

The European Union is partly to blame for this debacle. It approached vaccine procurement in its right-minded European way, using the purchasing power of a bloc that represents 446 million people to negotiate for lower prices, and protecting the people’s interests by holding pharmaceutical companies responsible in case of problems with new vaccines rushed to market. By contrast, early last year, Donald Trump and his British fraternal twin, Boris Johnson, moved swiftly to partner with drug companies in vaccine development, dismissed liability concerns, and secured first dibs on the end product.

So far, the Anglo-American approach looks like the better one: The United States is already awash with vaccines, and expects more than a billion doses to be delivered by the end of this year. Americans are getting vaccinated at an astonishing clip—an average of 2 million shots in a single day—while here in France, three months into the vaccination campaign, only 2.5 million people, out of a population of 67 million, had been fully vaccinated as of March 24. The United Kingdom has also been vaccinating up a storm. Add a little post-Brexit bitterness to our seething European envy when we see more than 844,000 people vaccinated on a single day in Britain. While less than 10 percent of the French population has received a first dose at this point, 29 million Britons have had their first jab.

The bitterness we feel watching Britain and the United States do better is compounded by a sense of unfairness. European countries, unlike the majority of countries in the world, have the wherewithal to produce their own COVID-19 vaccines. AstraZeneca is an Anglo-Swedish company. Pfizer’s vaccine was developed jointly with BioNTech, which is German. The multinational corporation Johnson & Johnson manufactures in Europe. The problem is that not all the vaccines produced in Europe stay in Europe. While the European Union has struggled to fulfill its vaccine needs, it’s been exporting vaccines to countries around the world—some 41 million doses to more than 30 countries, including 10 million to Britain and even a million doses to the United States. Exasperated, the EU moved on March 24 to block for six weeks the export of vaccines produced in Europe to countries with higher vaccination rates.

Europe’s frustrations are particularly understandable with the Johnson & Johnson vaccine. A multinational giant with a global supply chain, J&J produces COVID-19 vaccine in Europe and ships it to the United States for bottling. But the finished vials are blocked from being re-exported to Europe, thanks to “an outright ban on the export of vaccines or vaccine components,” the European Council president, Charles Michel, has complained. Europe learned during the Trump years that it could not count on the United States. It’s learning now that in an era of vaccine nationalism, the moral high ground of international cooperation has yielded in the United States and Britain to an our-people-first-because-we-can approach to a terrible global crisis.

Perhaps I shouldn’t be surprised that when the priorities of pandemic management shifted away from good daily governance to a scramble for resources, America came out ahead. One way of interpreting what’s happening is that, although Trump is no longer president of the United States, it’s still “America First.” “We’re going to start off making sure Americans are taken care of first,” President Joe Biden said earlier this month. And he is: At this point, 26 out of every 100 Americans have received a vaccine dose. Compare that with 14 out of 100 in Spain, Italy, Germany, and France—or a mere 3.9 in India.

Millions of doses are due to arrive in Europe in the coming months. They can’t get here soon enough. As the more contagious and more virulent U.K. variant becomes dominant in Europe, hospitalizations and deaths are rising once again. Europe’s economy and social fabric risk long-term damage from more than a year of coronavirus shutdowns.

The race here between the virus and getting people vaccinated is neck and neck, and it’s a race that Europe must win, not only for Europeans, but as a major vaccine producer that has always been willing to share in an equitable global system. We have the best chance of winning this race with cooperation from the United States, if it would only back down a bit from America First. Biden will virtually attend the European Council’s vaccine summit on Friday. Export bans on vaccines and their components will be on the agenda. As an American living in Europe, I ask you, Mr. President, to make me proud—and help me and hundreds of millions of others in Europe and around the world get vaccinated.
Newsletter

Related Articles

Beautiful Virgin Islands
0:00
0:00
Close
Munich Airport Reopens After Second Drone Shutdown
France Names New Government Amid Political Crisis
Trump Stands Firm in Shutdown Showdown and Declares War on Drug Cartels — Turning Crisis into Opportunity
Surge of U.S. Billionaires Transforms London’s Peninsula Apartments into Ultra-Luxury Stronghold
Pro Europe and Anti-War Babiš Poised to Return to Power After Czech Parliamentary Vote
Jeff Bezos Calls AI Surge a ‘Good’ Bubble, Urges Focus on Lasting Innovation
Japan’s Ruling Party Chooses Sanae Takaichi, Clearing Path to First Female Prime Minister
Sean ‘Diddy’ Combs Sentenced to Fifty Months in Prison Following Prostitution Conviction
Taylor Swift’s ‘Showgirl’ Launch Extends Billion-Dollar Empire
Trump Administration Launches “TrumpRx” Plan to Enable Direct Drug Sales at Deep Discounts
Trump Announces Intention to Impose 100 Percent Tariff on Foreign-Made Films
Altman Says GPT-5 Already Outpaces Him, Warns AI Could Automate 40% of Work
Singapore and Hong Kong Vie to Dominate Asia’s Rising Gold Trade
Trump Organization Teams with Saudi Developer on $1 Billion Trump Plaza in Jeddah
Manhattan Sees Surge in Office-to-Housing Conversions, Highest Since 2008
Switzerland and U.S. Issue Joint Assurance Against Currency Manipulation
Electronic Arts to Be Taken Private in Historic $55 Billion Buyout
Thomas Jacob Sanford Named as Suspect in Deadly Michigan Church Shooting and Arson
Russian Research Vessel 'Yantar' Tracked Mapping Europe’s Subsea Cables, Raising Security Alarms
New York Man Arrested After On-Air Confession to 2017 Parents’ Murders
U.S. Defense Chief Orders Sudden Summit of Hundreds of Generals and Admirals
Global Cruise Industry Posts Dramatic Comeback with 34.6 Million Passengers in 2024
Trump Claims FBI Planted 274 Agents at Capitol Riot, Citing Unverified Reports
India: Internet Suspended in Bareilly Amid Communal Clashes Between Muslims and Hindus
Supreme Court Extends Freeze on Nearly $5 Billion in U.S. Foreign Aid at Trump’s Request
Archaeologists Recover Statues and Temples from 2,000-Year-Old Sunken City off Alexandria
China Deploys 2,000 Workers to Spain to Build Major EV Battery Factory, Raising European Dependence
Speed Takes Over: How Drive-Through Coffee Chains Are Rewriting U.S. Coffee Culture
U.S. Demands Brussels Scrutinize Digital Rules to Prevent Bias Against American Tech
Ringo Starr Champions Enduring Beatles Legacy While Debuting Las Vegas Art Show
Private Equity’s Fundraising Surge Triggers Concern of European Market Shake-Out
Colombian President Petro Vows to Mobilize Volunteers for Gaza and Joins List of Fighters
FBI Removes Agents Who Kneeled at 2020 Protest, Citing Breach of Professional Conduct
Trump Alleges ‘Triple Sabotage’ at United Nations After Escalator and Teleprompter Failures
Shock in France: 5 Years in Prison for Former President Nicolas Sarkozy
Tokyo’s Jimbōchō Named World’s Coolest Neighbourhood for 2025
European Officials Fear Trump May Shift Blame for Ukraine War onto EU
BNP Paribas Abandons Ban on 'Controversial Weapons' Financing Amid Europe’s Defence Push
Typhoon Ragasa Leaves Trail of Destruction Across East Asia Before Making Landfall in China
The Personality Rights Challenge in India’s AI Era
Big Banks Rebuild in Hong Kong as Deal Volume Surges
Italy Considers Freezing Retirement Age at 67 to Avert Scheduled Hike
Italian City to Impose Tax on Visiting Dogs Starting in 2026
Arnault Denounces Proposed Wealth Tax as Threat to French Economy
Study Finds No Safe Level of Alcohol for Dementia Risk
Denmark Investigates Drone Incursion, Does Not Rule Out Russian Involvement
Lilly CEO Warns UK Is ‘Worst Country in Europe’ for Drug Prices, Pulls Back Investment
Nigel Farage Emerges as Central Force in British Politics with Reform UK Surge
Disney Reinstates ‘Jimmy Kimmel Live!’ after Six-Day Suspension over Charlie Kirk Comments
U.S. Prosecutors Move to Break Up Google’s Advertising Monopoly
×